Turner Investments’s MacroGenics MGNX Stock Holding History

Turner Investments’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-8,480	Closed	-$232K	–	682
2013 Q4	$232K	Buy	+8,480	New	+$222K	﹤0.01%	552

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

SCA

SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Turner Investments's MGNX Position: Q1 2014 in Review

Turner Investments sold out of MacroGenics (MGNX) in Q1 2014, closing a stake of 8,480 shares — an estimated $232K sold.

Turner Investments first reported a position in MGNX in Q4 2013 and held it in 1 quarter. The position peaked at $232K in Q4 2013. 75 funds tracked by Wall St. Rank hold MGNX as of Q1 2014.

Turner Investments reported no remaining MacroGenics position as of Q1 2014 after selling out during the quarter.
Turner Investments sold 8,480 MacroGenics shares in Q1 2014, an estimated $232K.
Turner Investments first reported a position in MacroGenics in Q4 2013 and held it in 1 quarter.
Turner Investments's MacroGenics position peaked at $232K in Q4 2013.
75 funds tracked by Wall St. Rank held MacroGenics as of Q1 2014.

Based on Turner Investments's 13F filing for Q1 2014, filed 12 May 2014.